NCT05451043 2025-06-26
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
AHS Cancer Control Alberta
Phase 2 Recruiting
Clinical Trials
12 trialsNCT06775080 2025-01-14
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Huashan Hospital
Phase 2 Recruiting
NCT06145074 2024-03-28
IMPULS
Zealand University Hospital
Phase 2 Recruiting
NCT02013492 2022-12-06
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT04005365 2019-11-26
Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer
Central South University
Phase 2 Unknown
NCT03838029 2019-11-20
BC-PC
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT01451658 2019-09-04
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01970748 2019-08-30
P-HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT03919461 2019-04-18
COMPIT-2
Assaf-Harofeh Medical Center
Phase 2 Recruiting
NCT03245554 2018-04-09
Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol
Central South University
Phase EARLY_PHASE1 Unknown
NCT00888797 2011-07-12
β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence
Sheba Medical Center
Phase 3 Unknown
NCT01298284 2011-06-15
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown